81518 prior authorization | Blue Cross Blue Shield Oklahoma
81518, Oncology (Breast) Mrna Gene Expression Profiling By Real-Time Rt- Pcr Of 11 Genes (7 Content And 4 Housekeeping) Utilizing Formalin- Fixed Paraffin-Embedded Tissue Algorithms Reported As Percentage Risk For Metastatic Recurrence And Likelihood Of Benefit From Extended Endocrine Therapy, is on the Blue Cross Blue Shield Oklahoma commercial prior authorization list. Not a coverage or referral decision.
- Code
- 81518
- Description
- Oncology (Breast) Mrna Gene Expression Profiling By Real-Time Rt- Pcr Of 11 Genes (7 Content And 4 Housekeeping) Utilizing Formalin- Fixed Paraffin-Embedded Tissue Algorithms Reported As Percentage Risk For Metastatic Recurrence And Likelihood Of Benefit From Extended Endocrine Therapy
- Source
- 2026 Commercial Outpatient Medical Surgical Fully Insured Prior Authorization Codes, Pg 92 Original policy